Fingerprint
Dive into the research topics of 'Erratum: A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma (American Journal of Clinical Oncology (December 2004) 27, 6 (505-509))'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically